Avodart Cost in New Mexico 2026: Dutasteride Prices, Insurance, and Compounding Options

What Does Avodart Actually Cost in New Mexico in 2026?

Brand-name Avodart carries a manufacturer list price of roughly $290 per month in New Mexico, but almost no cash-pay patient pays that figure. Generic dutasteride 0.5 mg capsules are widely available at New Mexico retail pharmacies for an average cash price of approximately $25 per month in 2026, representing more than a 90% reduction from the brand list price. Discount programs can push that number even lower.

The price gap between brand and generic dutasteride exists because multiple manufacturers, including Zydus, Amneal, and Apotex, produce FDA-approved generic versions following the expiration of GSK's patent. The FDA's Orange Book confirms therapeutic equivalence for all AB-rated generics [1]. At CVS, Walgreens, and Walmart pharmacies across Albuquerque, Santa Fe, and Las Cruces, GoodRx coupons have consistently placed the 30-capsule fill of generic dutasteride 0.5 mg between $18 and $30 depending on which chain you use and which coupon platform applies. Walmart's $4/$10 generic program does not list dutasteride as of early 2026, but the chain's pharmacy discount pricing still brings a 30-count to approximately $22.

Dutasteride is a dual 5-alpha reductase inhibitor (5-ARI) blocking both type 1 and type 2 isoenzymes, which distinguishes it pharmacologically from finasteride (a type 2-only inhibitor) [2]. That dual inhibition drops serum dihydrotestosterone (DHT) by approximately 90% versus roughly 70% for finasteride according to comparative pharmacology data published by the FDA [3]. Whether that added DHT suppression translates to meaningfully better clinical outcomes in benign prostatic hyperplasia (BPH) or androgenetic alopecia remains debated, but it is the reason some prescribers and patients prefer dutasteride despite the slightly higher cost.

The COMbAT trial (N=4,844, 4-year follow-up) showed that combination dutasteride 0.5 mg plus tamsulosin reduced the risk of acute urinary retention by 67.8% compared to tamsulosin alone (P<0.001) [4]. That trial used brand Avodart but the generic is bioequivalent. For a New Mexico patient on a combination regimen, the monthly generic dutasteride cost of ~$25 plus generic tamsulosin of ~$6 totals approximately $31, compared to a brand-only approach that would exceed $300.

Does New Mexico Medicaid Cover Dutasteride?

New Mexico Medicaid does not cover Avodart or generic dutasteride for benign prostatic hyperplasia or for off-label androgenetic alopecia under its 2025-2026 Preferred Drug List. The New Mexico Human Services Department administers Medicaid pharmacy benefits through managed care organizations, each maintaining their own formularies, but none of the current managed care contracts list dutasteride as a preferred or non-preferred covered drug without a specific prior authorization exception.

Patients enrolled in Centennial Care, New Mexico's consolidated Medicaid program, may file a prior authorization request if a prescriber documents medical necessity and failure of covered alternatives. Covered BPH alternatives on the NM Medicaid formulary include alpha-blockers such as tamsulosin and terazosin, plus finasteride (a Type 2-only 5-ARI). If finasteride has failed or is contraindicated, a prescriber may submit documentation to support dutasteride coverage, though approval is not guaranteed and the appeals process takes 14 to 30 days under federal Medicaid timelines [5].

Medicare Part D plans available to New Mexico beneficiaries in 2026 vary. Generic dutasteride appears on Tier 2 or Tier 3 of several Part D formularies, which typically means a copay between $10 and $45 per month after the deductible. Patients enrolled in a Low Income Subsidy (Extra Help) program may see that cost reduced to $4.50 per generic fill. Checking the Medicare Plan Finder at medicare.gov before the annual enrollment window (October 15 to December 7) is the most reliable way to compare plans covering dutasteride in New Mexico.

Is Compounded Dutasteride Legal in New Mexico?

Compounded dutasteride is legal in New Mexico when prepared and dispensed by a licensed 503A pharmacy operating under the federal Drug Quality and Security Act (DQSA) and New Mexico Board of Pharmacy regulations [6]. A 503A pharmacy compounds for individual patients based on a valid prescription from a licensed prescriber. Compounded dutasteride prepared this way is not FDA-approved, but it is federally and state-legally permissible.

Compounded dutasteride from a New Mexico 503A pharmacy typically costs approximately $40 per month. That is higher than the $25 cash-pay generic, but compounded formulations can be customized. Some patients prefer compounded topical dutasteride preparations for androgenetic alopecia to minimize systemic DHT suppression, though the FDA has not approved any topical 5-ARI formulation and clinical evidence for topical dutasteride is limited to smaller studies [7].

503B outsourcing facilities, which manufacture large batches without patient-specific prescriptions, cannot legally compound dutasteride unless it appears on the FDA's 503B bulks list. As of early 2026, dutasteride does not appear on that list, so bulk-compounded dutasteride from a 503B facility is not lawful. Patients receiving compounded dutasteride should confirm that the pharmacy holds a current 503A license from the New Mexico Board of Pharmacy or is an out-of-state 503A pharmacy licensed to ship to New Mexico. The New Mexico Board of Pharmacy license verification tool is available at rld.nm.gov.

Eun et al. (J Am Acad Dermatol, 2010; N=153) found that oral dutasteride 0.5 mg/day over 24 weeks produced significantly greater improvement in hair count compared to placebo in men with androgenetic alopecia (P<0.001) [8]. That trial used the oral 0.5 mg dose, not a compounded topical, and serves as the most frequently cited randomized evidence for dutasteride's off-label hair loss use.

Can a New Mexico Resident Get Dutasteride via Telehealth?

Telehealth prescribing of dutasteride is legal in New Mexico. New Mexico's telehealth statute (NMSA 1978, Section 24-25-5) permits prescribing via synchronous audio-video encounters, and the state adopted permanent telehealth flexibilities following the COVID-19 public health emergency [9]. A prescriber licensed in New Mexico may conduct a virtual visit, evaluate a patient's BPH symptoms or pattern hair loss, and issue a dutasteride prescription that a New Mexico or mail-order pharmacy can fill.

Platforms operating in New Mexico include national telehealth services and state-licensed providers. Patients should confirm that the prescribing clinician holds an active New Mexico medical license (searchable at nmmb.state.nm.us). Prescriptions for dutasteride cannot be issued without a valid prescriber-patient relationship, which telehealth establishes through the initial video visit.

HealthRX clinicians see New Mexico patients for dutasteride consultations via video. After a clinical review, a prescription may be sent to the patient's preferred local pharmacy or to a mail-order pharmacy. Processing typically takes 24 to 48 hours. Follow-up lab monitoring, including PSA (prostate-specific antigen) baseline and 6-month recheck, is coordinated through the same platform [10].

Dutasteride lowers PSA by approximately 50% after 3 to 6 months of use. The American Urological Association guideline on BPH recommends that clinicians document a baseline PSA before starting a 5-ARI and communicate to the patient that a PSA result on dutasteride should be doubled to estimate the true underlying value for prostate cancer screening purposes [11]. Telehealth prescribers operating in New Mexico are bound by the same standard of care as in-person prescribers on this point.

Which Private Insurance Plans Cover Avodart in New Mexico?

Private insurance coverage for dutasteride in New Mexico depends entirely on the plan's formulary. Generic dutasteride (not brand Avodart) appears on Tier 2 of most commercial formularies operating in New Mexico, including those administered by Presbyterian Health Plan, Blue Cross Blue Shield of New Mexico, and Molina Healthcare's commercial products. A Tier 2 copay for a 30-day supply typically falls between $15 and $50 depending on deductible status.

Brand-name Avodart is rarely covered at a preferred tier. Most New Mexico commercial plans place brand Avodart on Tier 3 or Tier 4, which may result in a cost share of $75 to $150 per month or a percentage coinsurance after deductible. GSK maintains a savings card program that can reduce the brand out-of-pocket cost, but the card cannot be used with any government-funded insurance, including Medicaid, Medicare, or TRICARE [12].

For off-label prescribing, specifically androgenetic alopecia, most commercial plans in New Mexico apply a cosmetic exclusion and will not cover dutasteride regardless of tier. A prior authorization submitted with a diagnosis code for androgenetic alopecia (ICD-10 L64.9) is almost always denied under cosmetic-exclusion language. Prescribers sometimes submit BPH codes when patients have both conditions, which may improve the odds of coverage but must accurately reflect the clinical picture to comply with billing regulations.

Employees covered under self-funded employer health plans governed by ERISA may face different formulary rules, since ERISA preempts most state insurance mandates. A benefits coordinator or HR department can clarify whether dutasteride is covered under a specific self-funded plan.

What Are the Cheapest Ways to Get Dutasteride in New Mexico?

Generic dutasteride at $25 per month through a GoodRx or RxSaver coupon at a major New Mexico retail pharmacy is the lowest-cost option for most cash-pay patients. Prices at independent pharmacies in smaller New Mexico cities such as Roswell, Farmington, and Clovis may differ from chain prices; calling ahead with the GoodRx coupon code is advisable [13].

Mail-order pharmacies licensed in New Mexico, including Amazon Pharmacy, Cost Plus Drugs (Mark Cuban's Cost Plus Drugs), and GoodRx Care's pharmacy partner network, often offer 90-day supplies at a per-unit cost lower than 30-day fills. Cost Plus Drugs lists generic dutasteride 0.5 mg at a published acquisition-plus-markup price that is frequently below $20 for 30 capsules, though patients should verify current pricing directly on the platform [14].

Patient Assistance Programs (PAPs) run by GSK include the GSK Patient Assistance Program (1-888-825-5249), which provides brand Avodart at no cost to uninsured or underinsured patients meeting income criteria. New Mexico residents earning up to 400% of the federal poverty level may qualify. Applications require a prescriber signature and proof of income [15].

State-run pharmaceutical assistance programs in New Mexico are limited. New Mexico does not operate a broad state pharmaceutical assistance program equivalent to those in Pennsylvania (PACE) or New Jersey (PAAD). The New Mexico Aging and Long-Term Services Department does maintain a pharmaceutical assistance resource list for seniors, but direct drug cost subsidies for dutasteride are not currently available through a state-funded mechanism.

HealthRX New Mexico Dutasteride Cost Decision Framework (2026)

The following decision path summarizes how a New Mexico patient should approach dutasteride cost:

1. Check if you have commercial insurance: if yes, request generic dutasteride at Tier 2 and verify that a 90-day mail-order supply is available.
2. If on Medicare Part D: use the Medicare Plan Finder to identify plans with the lowest dutasteride tier before the next enrollment period.
3. If uninsured or cash-pay: use GoodRx or RxSaver to obtain generic dutasteride for approximately $25 per month at a major retail chain.
4. If interested in compounding for topical or customized dosing: confirm the pharmacy holds a current New Mexico 503A license before proceeding.
5. If on New Mexico Medicaid and finasteride has failed: ask the prescriber to file a prior authorization for dutasteride with documented clinical justification.

This five-step path covers the vast majority of New Mexico patients seeking dutasteride in 2026 [16].

How Does PSA Monitoring Affect Dutasteride Prescribing in New Mexico?

PSA monitoring is a clinical and legal responsibility that no New Mexico prescriber, telehealth or in-person, can skip. Dutasteride's suppression of PSA by approximately 50% after 6 months is well-documented in the REDUCE trial (N=8,231), which also showed that dutasteride 0.5 mg/day over 4 years reduced the relative risk of prostate cancer diagnosis on biopsy by 22.8% (P<0.001) [17]. That trial simultaneously identified an imbalance in high-grade Gleason score 8-10 cancers in the dutasteride arm, which led the FDA to add a warning to the Avodart label stating that 5-ARIs should not be used to reduce prostate cancer risk outside of an approved indication [18].

The practical implication for New Mexico patients: any prescriber issuing dutasteride for BPH should obtain a baseline PSA, document a 6-month PSA to establish a new baseline on therapy, and communicate to the patient that the apparent PSA value on the lab report should be multiplied by 2 to estimate the untreated equivalent. Failure to do this can result in a missed or delayed prostate cancer diagnosis. The American Cancer Society recommends shared decision-making discussions about prostate cancer screening starting at age 50 for average-risk men and age 40 to 45 for high-risk individuals [19].

Side Effects and Safety Considerations Relevant to Cost Decisions

Cost decisions do not happen in isolation from safety. Sexual side effects of dutasteride, including decreased libido (reported in 3-5% of patients in key trials), erectile dysfunction (~1.7%), and ejaculatory dysfunction (~1.4%), can affect adherence and thus the real-world cost per benefit obtained [20]. Post-marketing reports of persistent sexual dysfunction after stopping 5-ARIs exist, though causality at the population level remains uncertain.

The FDA's current Avodart prescribing information includes a class-wide 5-ARI warning about breast cancer risk based on post-marketing reports, though absolute risk remains very low [18]. Gynecomastia was reported in approximately 1.1% of patients in the COMbAT trial [4]. These considerations should be part of the informed consent discussion at the telehealth or in-person visit, not afterthoughts.

A patient who experiences a side effect that causes discontinuation after one month has spent $25 on generic dutasteride with no durable benefit. A prescriber who identifies a patient with elevated cardiovascular risk, a PSA already above 10 ng/mL, or prior breast cancer should weigh whether the BPH indication is strong enough to proceed, since the cost of downstream diagnostic workup far exceeds the $25/month drug cost.

Dutasteride vs. Finasteride: Does the Price Difference Matter in New Mexico?

Generic finasteride 5 mg (for BPH) costs approximately $10 to $15 per month in New Mexico using cash-pay discount programs, and finasteride 1 mg (Propecia-equivalent) for hair loss costs approximately $15 to $25 per month. Generic dutasteride at $25 per month costs roughly 1.5 to 2.5 times more than the comparable finasteride option.

Whether the extra cost is worth it depends on the clinical situation. For BPH, the AUA guideline notes that both agents are appropriate first-line 5-ARIs with similar efficacy for prostate volume reduction; the choice is often driven by tolerability and cost rather than outcome data [11]. For androgenetic alopecia, a 2019 network meta-analysis published in JAMA Dermatology (N=over 2,000 across 23 trials) found that dutasteride 0.5 mg/day produced numerically superior hair count improvements compared to finasteride 1 mg/day, though head-to-head trial data remain sparse [21].

If the additional hair count improvement from dutasteride matters to a patient, the incremental cost of approximately $10 to $15 per month over finasteride is small. New Mexico patients who are price-sensitive and primarily treating BPH with no hair loss concern should default to generic finasteride first, per standard cost-effective prescribing principles.